Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00943098Phase 3Completed
Phase 3, randomised trial of diclofenac in odontalgia (2 arms), sponsored by IBSA Group. Primary endpoint: Pain Intensity Difference at 1.5 hours. Started Sep 2009; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00943098.